CCR5 and hepatocellular carcinoma: In absence of Ccne1, HCC progression was characterised by a reduced number of activated myofibroblasts, infiltrating immature MDSCs and differentiated inflammatory TAMs, which was confirmed by reduced mRNA levels of Col1a1 and the myeloid chemokine receptors Ccr2/Ccr5.